25-OCT-2025 6:10

SWOG Latin America Initiative ACCRUAL REPORT - Historic Registrations

SWOG/
Support		 STUDY R
E
G		 O
P
E
N		 ARM ACCR.
GOAL		 TOTAL
REGS.		 REGS.
LAST
12
Month		 REGS.
LAST
6
Month		 REGS.
LAST
3
Month		 REGS.
LAST
30
DAYS		 REGS.
LAST
7
DAYS		 DATE OF
FIRST
REG.		 # of
ACT.
INSTs		 # of
CURR
IRBs
SWOG S1007-Breast,Adj,N1,Endocrine+/-Chemo 1 N 1 Recurrence Score testing 9400 148 0 0 0 0 0 02/28/2011 478 185
            148 0 0 0 0 0      
 
    2 N 2 Chemo and Endocrine Therapy 5000 48 0 0 0 0 0 02/28/2011    
        3 Endocrine Therapy Alone   59 0 0 0 0 0      
            107 0 0 0 0 0      
 
  S1316-Compar. Effectiv. Trial for MBO 1 N 1 Randomization Surgery 220 10 0 0 0 0 0 05/11/2015    
        2 Randomization Non-surgical Management   6 0 0 0 0 0      
            16 0 0 0 0 0      
 
  S1501-Surv, Breast Stg IV, Card Tox w/ Carvedilol 1 Y 0 Screening 491 2 2 2 0 0 0 11/01/2017 249 87
            2 2 2 0 0 0      
 
    2 Y 3 Observation 491 2 2 2 1 0 0 11/01/2017    
            2 2 2 1 0 0      
 
  S1703-Met Breast, STM-monitoring v Usual Care 1 Y 0 Screening 739 33 22 12 6 5 0 09/17/2018 225 92
            33 22 12 6 5 0      
 
    2 Y 1 Control (Usual Care) 498 5 4 1 0 0 0 09/17/2018    
        2 Intervention (STMDDM)   5 5 2 2 0 0      
            10 9 3 2 0 0      
 
  S1714-CIPN Risk Prediction Cohort Study, Taxanes 1 N 1 Observation 1050 80 0 0 0 0 0 05/14/2019 4 1
            80 0 0 0 0 0      
 
  S1802-Pros, Stg IV, SST ± Surg/RT to Primary Tum 1 Y 0 Induction SST 1273 49 20 10 1 1 0 09/24/2018 328 138
            49 20 10 1 1 0      
 
    2 Y 1 Standard Systemic Therapy Only 1273 17 11 6 2 1 0 09/24/2018    
        2 SST + Surgery/RT   15 6 3 1 1 0      
            32 17 9 3 2 0      
 
  S1827-SCLC, MRI Surveillance +/- PCI 1 Y 1 PCI + MRI brain surveillance 668 7 3 1 0 0 0 05/04/2020 345 129
        2 MRI brain surveillance   3 2 0 0 0 0      
            10 5 1 0 0 0      
 
  S2010-ASPEN: Brst, Stg I-III, ASM vs Pt Ed 1 N 1 Active Symptom Monitoring + Patient Education 540 25 9 0 0 0 0 03/29/2023 2 1
        2 Patient Education   30 9 0 0 0 0      
            55 18 0 0 0 0      
 
  S2013-I-CHECKIT: ICI toxicity risk prediction study 1 Y 1 Observation Arm 3609 44 0 0 0 0 0 09/13/2021 230 115
            44 0 0 0 0 0      
 
  S2212-Breast, TNBC, Neoadj Chemo + Pembro 1 Y 1 Carbo + Paclitaxel + Pembro -> AC + Pembro 2400 5 5 5 1 1 0 09/15/2023 397 155
        2 Carbo + Docetaxel + Pembro   4 4 4 1 0 0      
            9 9 9 2 1 0      
 
  S0702-Zoledronic Acid ONJ Registry 1 N 1 Observation for ONJ 3500 57 0 0 0 0 0 01/30/2009    
            57 0 0 0 0 0      
 
  S0819-NSCLC, ADV, CHEMO/BEV +/-CET 1 N 1 Chemo+/-Bev w/o Cetuximab 1700 1 0 0 0 0 0 08/13/2009    
        2 Chemo+/-Bev w/ Cetuximab   1 0 0 0 0 0      
            2 0 0 0 0 0      
 
No EA1151-Prev, Tomosynthesis Mammographic Screening 1 E Total Registrations   105 60 0 0 0 0 01/30/2018 211 83
            105 60 0 0 0 0      
 
  NRGBR009-Breast, EarlyStg, Adjuvant Chemo 1 E Total Registrations   4 4 4 3 3 1 01/31/2024 476 194
            4 4 4 3 3 1      
 
    2 E Total Registrations   2 2 2 2 2 2 01/31/2024    
            2 2 2 2 2 2      
 

25-OCT-2025 6:10

SWOG Latin America Initiative ACCRUAL REPORT - Historic Registrations

INCan

SWOG/
Support		 STUDY R
E
G		 O
P
E
N		 ARM ACCR.
GOAL		 TOTAL
REGS.		 REGS.
LAST
12
Month		 REGS.
LAST
6
Month		 REGS.
LAST
3
Month		 REGS.
LAST
30
DAYS		 REGS.
LAST
7
DAYS		 DATE OF
FIRST
REG.		 # of
ACT.
INSTs		 # of
CURR
IRBs
SWOG S1007-Breast,Adj,N1,Endocrine+/-Chemo 1 N 1 Recurrence Score testing 9400 132 0 0 0 0 0 02/28/2011 478 185
            132 0 0 0 0 0      
 
    2 N 2 Chemo and Endocrine Therapy 5000 44 0 0 0 0 0 02/28/2011    
        3 Endocrine Therapy Alone   52 0 0 0 0 0      
            96 0 0 0 0 0      
 
  S1316-Compar. Effectiv. Trial for MBO 1 N 1 Randomization Surgery 220 5 0 0 0 0 0 05/11/2015    
        2 Randomization Non-surgical Management   3 0 0 0 0 0      
            8 0 0 0 0 0      
 
  S1703-Met Breast, STM-monitoring v Usual Care 1 Y 0 Screening 739 9 9 5 1 1 0 09/17/2018 225 92
            9 9 5 1 1 0      
 
    2 Y 1 Control (Usual Care) 498 1 1 0 0 0 0 09/17/2018    
        2 Intervention (STMDDM)   1 1 1 1 0 0      
            2 2 1 1 0 0      
 
  S1714-CIPN Risk Prediction Cohort Study, Taxanes 1 N 1 Observation 1050 60 0 0 0 0 0 05/14/2019 4 1
            60 0 0 0 0 0      
 
  S1802-Pros, Stg IV, SST ± Surg/RT to Primary Tum 1 Y 0 Induction SST 1273 40 20 10 1 1 0 09/24/2018 328 138
            40 20 10 1 1 0      
 
    2 Y 1 Standard Systemic Therapy Only 1273 15 9 6 2 1 0 09/24/2018    
        2 SST + Surgery/RT   11 5 3 1 1 0      
            26 14 9 3 2 0      
 
  S1827-SCLC, MRI Surveillance +/- PCI 1 Y 1 PCI + MRI brain surveillance 668 5 1 1 0 0 0 05/04/2020 345 129
        2 MRI brain surveillance   3 2 0 0 0 0      
            8 3 1 0 0 0      
 
  S2010-ASPEN: Brst, Stg I-III, ASM vs Pt Ed 1 N 1 Active Symptom Monitoring + Patient Education 540 16 8 0 0 0 0 03/29/2023 2 1
        2 Patient Education   11 6 0 0 0 0      
            27 14 0 0 0 0      
 
  S2013-I-CHECKIT: ICI toxicity risk prediction study 1 Y 1 Observation Arm 3609 13 0 0 0 0 0 09/13/2021 230 115
            13 0 0 0 0 0      
 
  S2212-Breast, TNBC, Neoadj Chemo + Pembro 1 Y 1 Carbo + Paclitaxel + Pembro -> AC + Pembro 2400 5 5 5 1 1 0 09/15/2023 397 155
        2 Carbo + Docetaxel + Pembro   4 4 4 1 0 0      
            9 9 9 2 1 0      
 
  S0702-Zoledronic Acid ONJ Registry 1 N 1 Observation for ONJ 3500 57 0 0 0 0 0 01/30/2009    
            57 0 0 0 0 0      
 
  S0819-NSCLC, ADV, CHEMO/BEV +/-CET 1 N 1 Chemo+/-Bev w/o Cetuximab 1700 1 0 0 0 0 0 08/13/2009    
        2 Chemo+/-Bev w/ Cetuximab   1 0 0 0 0 0      
            2 0 0 0 0 0      
 
No NRGBR009-Breast, EarlyStg, Adjuvant Chemo 1 E Total Registrations   4 4 4 3 3 1 01/31/2024 476 194
            4 4 4 3 3 1      
 
    2 E Total Registrations   2 2 2 2 2 2 01/31/2024    
            2 2 2 2 2 2      
 

25-OCT-2025 6:10

SWOG Latin America Initiative ACCRUAL REPORT - Historic Registrations

INC, Bogota

SWOG/
Support		 STUDY R
E
G		 O
P
E
N		 ARM ACCR.
GOAL		 TOTAL
REGS.		 REGS.
LAST
12
Month		 REGS.
LAST
6
Month		 REGS.
LAST
3
Month		 REGS.
LAST
30
DAYS		 REGS.
LAST
7
DAYS		 DATE OF
FIRST
REG.		 # of
ACT.
INSTs		 # of
CURR
IRBs
SWOG S1007-Breast,Adj,N1,Endocrine+/-Chemo 1 N 1 Recurrence Score testing 9400 16 0 0 0 0 0 02/28/2011 478 185
            16 0 0 0 0 0      
 
    2 N 2 Chemo and Endocrine Therapy 5000 4 0 0 0 0 0 02/28/2011    
        3 Endocrine Therapy Alone   7 0 0 0 0 0      
            11 0 0 0 0 0      
 
  S1316-Compar. Effectiv. Trial for MBO 1 N 2 Randomization Non-surgical Management 220 1 0 0 0 0 0 05/11/2015    
            1 0 0 0 0 0      
 
  S1714-CIPN Risk Prediction Cohort Study, Taxanes 1 N 1 Observation 1050 10 0 0 0 0 0 05/14/2019 4 1
            10 0 0 0 0 0      
 
  S1802-Pros, Stg IV, SST ± Surg/RT to Primary Tum 1 Y 0 Induction SST 1273 4 0 0 0 0 0 09/24/2018 328 138
            4 0 0 0 0 0      
 
    2 Y 1 Standard Systemic Therapy Only 1273 1 1 0 0 0 0 09/24/2018    
        2 SST + Surgery/RT   1 0 0 0 0 0      
            2 1 0 0 0 0      
 
  S1827-SCLC, MRI Surveillance +/- PCI 1 Y 1 PCI + MRI brain surveillance 668 1 1 0 0 0 0 05/04/2020 345 129
            1 1 0 0 0 0      
 

25-OCT-2025 6:10

SWOG Latin America Initiative ACCRUAL REPORT - Historic Registrations

INEN

SWOG/
Support		 STUDY R
E
G		 O
P
E
N		 ARM ACCR.
GOAL		 TOTAL
REGS.		 REGS.
LAST
12
Month		 REGS.
LAST
6
Month		 REGS.
LAST
3
Month		 REGS.
LAST
30
DAYS		 REGS.
LAST
7
DAYS		 DATE OF
FIRST
REG.		 # of
ACT.
INSTs		 # of
CURR
IRBs
SWOG S1316-Compar. Effectiv. Trial for MBO 1 N 1 Randomization Surgery 220 5 0 0 0 0 0 05/11/2015    
        2 Randomization Non-surgical Management   2 0 0 0 0 0      
            7 0 0 0 0 0      
 
  S1501-Surv, Breast Stg IV, Card Tox w/ Carvedilol 1 Y 0 Screening 491 2 2 2 0 0 0 11/01/2017 249 87
            2 2 2 0 0 0      
 
    2 Y 3 Observation 491 2 2 2 1 0 0 11/01/2017    
            2 2 2 1 0 0      
 
  S1703-Met Breast, STM-monitoring v Usual Care 1 Y 0 Screening 739 19 9 5 4 4 0 09/17/2018 225 92
            19 9 5 4 4 0      
 
    2 Y 1 Control (Usual Care) 498 3 3 1 0 0 0 09/17/2018    
        2 Intervention (STMDDM)   3 3 1 1 0 0      
            6 6 2 1 0 0      
 
  S2010-ASPEN: Brst, Stg I-III, ASM vs Pt Ed 1 N 1 Active Symptom Monitoring + Patient Education 540 8 1 0 0 0 0 03/29/2023 2 1
        2 Patient Education   16 3 0 0 0 0      
            24 4 0 0 0 0      
 

25-OCT-2025 6:10

SWOG Latin America Initiative ACCRUAL REPORT - Historic Registrations

GOCCHI

SWOG/
Support		 STUDY R
E
G		 O
P
E
N		 ARM ACCR.
GOAL		 TOTAL
REGS.		 REGS.
LAST
12
Month		 REGS.
LAST
6
Month		 REGS.
LAST
3
Month		 REGS.
LAST
30
DAYS		 REGS.
LAST
7
DAYS		 DATE OF
FIRST
REG.		 # of
ACT.
INSTs		 # of
CURR
IRBs
SWOG S1714-CIPN Risk Prediction Cohort Study, Taxanes 1 N 1 Observation 1050 10 0 0 0 0 0 05/14/2019 4 1
            10 0 0 0 0 0      
 
  S1802-Pros, Stg IV, SST ± Surg/RT to Primary Tum 1 Y 0 Induction SST 1273 5 0 0 0 0 0 09/24/2018 328 138
            5 0 0 0 0 0      
 
    2 Y 1 Standard Systemic Therapy Only 1273 1 1 0 0 0 0 09/24/2018    
        2 SST + Surgery/RT   3 1 0 0 0 0      
            4 2 0 0 0 0      
 
  S1827-SCLC, MRI Surveillance +/- PCI 1 Y 1 PCI + MRI brain surveillance 668 1 1 0 0 0 0 05/04/2020 345 129
            1 1 0 0 0 0      
 
  S2013-I-CHECKIT: ICI toxicity risk prediction study 1 Y 1 Observation Arm 3609 9 0 0 0 0 0 09/13/2021 230 115
            9 0 0 0 0 0      
 
No EA1151-Prev, Tomosynthesis Mammographic Screening 1 E Total Registrations   105 60 0 0 0 0 01/30/2018 211 83
            105 60 0 0 0 0      
 

25-OCT-2025 6:10

SWOG Latin America Initiative ACCRUAL REPORT - Historic Registrations

Univ Rep - Fac Med

SWOG/
Support		 STUDY R
E
G		 O
P
E
N		 ARM ACCR.
GOAL		 TOTAL
REGS.		 REGS.
LAST
12
Month		 REGS.
LAST
6
Month		 REGS.
LAST
3
Month		 REGS.
LAST
30
DAYS		 REGS.
LAST
7
DAYS		 DATE OF
FIRST
REG.		 # of
ACT.
INSTs		 # of
CURR
IRBs
SWOG S1703-Met Breast, STM-monitoring v Usual Care 1 Y 0 Screening 739 5 4 2 1 0 0 09/17/2018 225 92
            5 4 2 1 0 0      
 
    2 Y 1 Control (Usual Care) 498 1 0 0 0 0 0 09/17/2018    
        2 Intervention (STMDDM)   1 1 0 0 0 0      
            2 1 0 0 0 0      
 
  S2010-ASPEN: Brst, Stg I-III, ASM vs Pt Ed 1 N 1 Active Symptom Monitoring + Patient Education 540 1 0 0 0 0 0 03/29/2023 2 1
        2 Patient Education   3 0 0 0 0 0      
            4 0 0 0 0 0      
 
  S2013-I-CHECKIT: ICI toxicity risk prediction study 1 Y 1 Observation Arm 3609 22 0 0 0 0 0 09/13/2021 230 115
            22 0 0 0 0 0